Terina Myers

Terina Myers

Auto-generated profile, based on publicly available information

Terina Myers

Department of Neurology, University of Alabama at Birmingham , 1720 7th Avenue South, SC650K, Birmingham, AL 35294 , USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
RLRonald M. Lazar
Ronald M. Lazar
VWVirginia G. Wadley
Virginia G. Wadley
TMTerina Myers
Terina Myers
MJMichael R. Jones
Michael R. Jones
DHDonald V. Heck
Donald V. Heck
GHGeorge Howard
George Howard
Background and Purpose: Studies of carotid artery disease have suggested that high-grade stenosis can affect cognition, even without stroke. The presence and degree of cognitive impairment in such patients have not been reported and compared with a demographically matched population-based cohort. Methods: We studied cognition in 1000 consecutive CREST-2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial) patients, a treatment trial for asymptomatic carotid disease. Cognitive assessment was after randomization but before assigned treatment. The cognitive battery was developed in the general population REGARDS Study (Reasons for Geographic and Racial Differences in Stroke), involving Word List Learning Sum, Word List Recall, and Word List fluency for animal names and the letter F. The carotid stenosis patients were >45 years old with ≥70% asymptomatic carotid stenosis and no history of prevalent stroke. The distribution of cognitive performance for the patients was standardized, accounting for age, race, and education using performance from REGARDS, and after further adjustment for hypertension, diabetes, dyslipidemia, and smoking. Using the Wald Test, we tabulated the proportion of Z scores less than the anticipated deviate for the population-based cohort for representative percentiles. Results: There were 786 baseline assessments. Mean age was 70 years, 58% men, and 52% right-sided stenosis. The overall Z score for patients was significantly below expected for higher percentiles ( P <0.0001 for 50th, 75th, and 95th percentiles) and marginally below expected for the 25th percentile ( P =0.015). Lower performance was attributed largely to Word List Recall ( P <0.0001 for all percentiles) and for Word List Learning (50th, 75th, and 95th percentiles below expected, P ≤0.01). The scores for left versus right carotid disease were similar. Conclusions: Baseline cognition of patients with severe carotid stenosis showed below normal cognition compared to the population-based cohort, controlling for demographic and cardiovascular risk factors. This cohort represents the largest group to date to demonstrate that poorer cognition, especially memory, in this disease. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02089217.

14 February 2023 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
ANAmani M. Norling
Amani M. Norling
ABAleena Bennett
Aleena Bennett
MCMichael Crowe
Michael Crowe
DLD. Leann Long
D. Leann Long
SNSara A. Nolin
Sara A. Nolin
AGAdam Gerstenecker
Adam Gerstenecker
Background: Many older adults take at least one prescription medication with anticholinergic (ACH) activity, which can impact the central nervous system and can lead to cognitive decline and impairment especially in an aging population susceptible to cognitive changes. We examined this relationship between ACH burden and cognitive function in middle‐aged and older adults. We further determined if increased activity levels mitigated the relationships between ACH burden and cognition. Methods: Data from The Reasons for Geographic and Racial Differences in Stroke project were used. We included 20,575 adults aged ≥45 years with longitudinal cognitive testing. The anticholinergic cognitive burden (ACB) scale was used to assess for ACH use and overall burden. Cognitive data included an overall composite score, a memory, and verbal fluency composites. Mixed effects models were conducted to determine if cognitive function worsened over time for participants with higher ACB (>3) scores. The full model adjusted for age, sex, race, education, diabetes, hypertension, cardiovascular disease, congestive heart failure, and dyslipidemia, self‐reported physical activity (PA) and depressive symptoms. Results: A significant relationship between ACH burden and composite cognitive scores was found ( p = 3) scores and ACB as a continuous variable. Baseline PA level was associated with less cognitive decline over time and this effect was greater in older cohorts. Conclusions: We observed an effect of ACHs on cognition in adults ≥45 years old that worsened with age. ACH users showed more cognitive effects, whereas PA emerged as a possible mitigating factor.

15 August 2023 in GeroScience
Verified
Journal Article
Closed access
PDF file
ANAmani M. Norling
Amani M. Norling
AGAdam Gerstenecker
Adam Gerstenecker
MBMark Bolding
Mark Bolding
LHLawrence Ver Hoef
Lawrence Ver Hoef
TBThomas Buford
Thomas Buford
RLRonald M. Lazar
Ronald M. Lazar

7 December 2023 in European Heart Journal Open
Verified
Journal Article
Open access
PDF file
RLRonald M Lazar
Ronald M Lazar
TMTerina Myers
Terina Myers
TGToby I Gropen
Toby I Gropen
MLMassoud A Leesar
Massoud A Leesar
JDJames Davies
James Davies
SKSusheel Kodali
Susheel Kodali
Aortic valve stenosis (AS) results in higher systolic pressure to overcome resistance from the stenotic valve, leading to heart failure and decline in cardiac output. There has been no assessment of cerebral blood flow (CBF) association with neurocognition in AS or the effects of valve replacement. The goal was to determine if AS is associated with altered cerebral haemodynamics and impaired neurocognition, and whether transcatheter aortic valve replacement (TAVR) improves haemodynamics and cognition. In 42 patients with planned TAVR, transcranial Doppler (TCD) assessed bilateral middle cerebral artery (MCA) mean flow velocities (MFVs); abnormality was <34.45 cm/s. The neurocognitive battery assessed memory, language, attention, visual–spatial skills, and executive function, yielding a composite Z-score. Impairment was <1.5 SDs below the normative mean. The mean age was 78 years, 59% Male, and the mean valve gradient was 46.87 mm/Hg. Mean follow-up was 36 days post-TAVR (range 27–55). Pre-TAVR, the mean MFV was 42.36 cm/s (SD = 10.17), and the mean cognitive Z-score was −0.22 SDs (range −1.99 to 1.08) below the normative mean. Among the 34 patients who returned after TAVR, the MFV was 41.59 cm/s (SD = 10.42), not different from baseline (P = 0.66, 2.28–3.67). Post-TAVR, average Z-scores were 0.17 SDs above the normative mean, not meeting the pre-specified threshold for a clinically significant 0.5 SD change. Among patients with severe AS, there was little impairment of MFV on TCD and no correlation with cognition. Transcatheter aortic valve replacement did not affect MFV or cognition. Assumptions about diminished CBF and improvement after TAVR were not supported. The relationship of cognition (Z-scores) to cerebral haemodynamics (mean flow velocity). Abnormality: ≥1.50 SD below normative means.